ACE2 expressions have no significant correlations with the prognoses of breast cancer, head neck squamous cell carcinoma, stomach adenocarcinoma and thyroid carcinoma (Supplementary Figure 1H–1K). The gene discussed is ACE2; the disease is gastric adenocarcinoma.